|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.95 USD | -4.09% |
|
-6.61% | -6.74% |
| 07/05 | Sarepta Therapeutics, Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| 07/05 | Earnings Flash (SRPT) Sarepta Therapeutics, Inc. Reports Q1 Revenue $730.8M | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.98x | 1.31x | -0.04x | 0.93x | 3.17x | 3.43x | -.--% | 219.6Cr | |
| -5.93x | -1.26x | 0.24x | 2.75x | -4.65x | -4.65x | -.--% | 256.57Cr | |
| Average | 0.03x | 0.03x | 0.10x | 1.84x | -0.74x | -0.61x | 0% | 238.08Cr | |
| Weighted average by Cap. | -0.43x | -0.07x | 0.11x | 1.91x | -1.04x | -0.92x | 0% |
- Stock Market
- Equities
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition